Free Trial
OTCMKTS:OTSKY

Otsuka Earnings Date & Estimates

Otsuka logo
$36.80 +0.68 (+1.88%)
As of 03:58 PM Eastern

Otsuka is estimated to report earnings on Friday, October 30, 2026, after market closes.

Upcoming Earnings Announcement

Announcement Date
Time
After Market Closes

What Analysts Expect from Otsuka

Otsuka is expected to post earnings of $0.5860 per share on revenue of $4.39 billion. Otsuka last reported on July 31, 2026, posting $0.70 per share and beating the $0.5060 consensus estimate.

Consensus Estimates

Consensus EPS
$0.5860
Expected Revenue
$4.39 billion

Recent Track Record

Last Reported
Q2 2026
Last Quarter EPS
$0.70 (Beat by +$0.1940)
Last Quarter Revenue
$4.41 billion

Otsuka Earnings FAQ

Otsuka (OTCMKTS:OTSKY) is estimated to report earnings on Friday, October 30, 2026, after market closes. This date is estimated from past reporting schedules and may change once the company confirms it.

Analysts expect Otsuka to post earnings of $0.5860 per share for the quarter.

The consensus revenue estimate for Otsuka is $4.39 billion for the quarter.

Otsuka Earnings Headlines

Otsuka (OTCMKTS:OTSKY) Shares Gap Down - Here's Why
My top 3 AI picks for the next decade
Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up Amazon and Netflix under $3 per share in 2005. Now the chief investment strategist at The Oxford Club has identified three AI stocks he believes could be the most profitable investments of the next decade.tc pixel
See More Otsuka Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Otsuka? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Otsuka and other key companies, straight to your email.

About Otsuka

Otsuka (OTCMKTS:OTSKY) Holdings Co., Ltd. is a Japan-based healthcare company that oversees the Otsuka Group’s pharmaceutical, nutraceutical and consumer health businesses. The company’s operations are primarily conducted through subsidiaries, including Otsuka Pharmaceutical Co., Ltd., which researches, develops, manufactures and markets prescription medicines, over-the-counter products and health-related foods.

Otsuka’s pharmaceutical activities focus on areas such as psychiatry, oncology, cardiovascular and renal medicine, and several other specialized therapeutic fields. Its nutraceutical and consumer health businesses offer products designed to support hydration, nutrition and general wellness, including the Pocari Sweat and Oronamin C brands in select markets. The group also has activities in medical devices and other health-related businesses.

Otsuka Holdings was established in 2008 as the holding company for the Otsuka Group and was listed on the Tokyo Stock Exchange in 2010. The group serves customers in Japan and international markets through research, manufacturing and commercial operations across North America, Europe, Asia and other regions. Tatsuo Higuchi serves as president and chief executive officer of Otsuka Holdings.

View Otsuka Profile